Comparing Accuracies of Length-Type Geographic Atrophy Growth Rate Metrics Using Atrophy-Front Growth Modeling
- PMID: 36245762
- PMCID: PMC9560575
- DOI: 10.1016/j.xops.2022.100156
Comparing Accuracies of Length-Type Geographic Atrophy Growth Rate Metrics Using Atrophy-Front Growth Modeling
Abstract
Purpose: To compare the accuracies of the previously proposed square-root-transformed and perimeter-adjusted metrics for estimating length-type geographic atrophy (GA) growth rates.
Design: Cross-sectional and simulation-based study.
Participants: Thirty-eight eyes with GA from 27 patients.
Methods: We used a previously developed atrophy-front growth model to provide analytical and numerical evaluations of the square-root-transformed and perimeter-adjusted growth rate metrics on simulated and semisimulated GA growth data.
Main outcome measures: Comparison of the accuracies of the square-root-transformed and perimeter-adjusted metrics on simulated and semisimulated GA growth data.
Results: Analytical and numerical evaluations showed that the accuracy of the perimeter-adjusted metric is affected minimally by baseline lesion area, focality, and circularity over a wide range of GA growth rates. Average absolute errors of the perimeter-adjusted metric were approximately 20 times lower than those of the square-root-transformed metrics, per evaluation on a semisimulated dataset with growth rate characteristics matching clinically observed data.
Conclusions: Length-type growth rates have an intuitive, biophysical interpretation that is independent of lesion geometry, which supports their use in clinical trials of GA therapeutics. Taken in the context of prior studies, our analyses suggest that length-type GA growth rates should be measured using the perimeter-adjusted metric, rather than square-root-transformed metrics.
Keywords: AREDS, Age-Related Eye Disease Study; GA; GA, geographic atrophy; Geographic atrophy; Growth modelling; Growth rate; RPE, retinal pigment epithelium.
© 2022 by the American Academy of Ophthalmology.
Figures







Similar articles
-
Geographic Atrophy Growth Is Strongly Related to Lesion Perimeter: Unifying Effects of Lesion Area, Number, and Circularity on Growth.Ophthalmol Retina. 2021 Sep;5(9):868-878. doi: 10.1016/j.oret.2020.12.002. Epub 2020 Dec 9. Ophthalmol Retina. 2021. PMID: 33307218 Clinical Trial.
-
Progression of cRORA (Complete RPE and Outer Retinal Atrophy) in Dry Age-Related Macular Degeneration Measured Using SD-OCT.Transl Vis Sci Technol. 2022 Jan 3;11(1):19. doi: 10.1167/tvst.11.1.19. Transl Vis Sci Technol. 2022. PMID: 35029632 Free PMC article.
-
Association of Hyperautofluorescence Signals with Geographic Atrophy Progression in the METformin for the MINimization of Geographic Atrophy Progression Trial.Ophthalmol Sci. 2024 Sep 12;5(1):100620. doi: 10.1016/j.xops.2024.100620. eCollection 2025 Jan-Feb. Ophthalmol Sci. 2024. PMID: 39584185 Free PMC article.
-
The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration.Ophthalmology. 2018 Mar;125(3):369-390. doi: 10.1016/j.ophtha.2017.08.038. Epub 2017 Oct 27. Ophthalmology. 2018. PMID: 29110945 Review.
-
En Face Imaging of Geographic Atrophy Using Different Swept-Source OCT Scan Patterns.Ophthalmol Retina. 2019 Feb;3(2):122-132. doi: 10.1016/j.oret.2018.09.004. Epub 2018 Sep 14. Ophthalmol Retina. 2019. PMID: 31014759 Review.
References
-
- Jaffe G.J., Westby K., Csaky K.G., et al. C5 inhibitor Avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2/3 trial. Ophthalmology. 2021;128:576–586. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources